| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/10/2004 | WO2004048326A1 Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient |
| 06/10/2004 | WO2004048319A1 Novel benzamide compounds for use in mch receptor related disorders |
| 06/10/2004 | WO2004048309A1 Vitamin d receptor modulators |
| 06/10/2004 | WO2004047738A2 Arylcyclopropylcarboxylic amides as potassium channel openers |
| 06/10/2004 | WO2004047730A2 Compounds for inhibition of hiv infection by blocking hiv entry |
| 06/10/2004 | WO2004027388A3 Novel green and orange fluorescent labels and their uses |
| 06/10/2004 | WO2003059265A3 Compositions and methods for treating heart failure |
| 06/10/2004 | US20040110964 use for regulating the degree of polymerization during the polymerization of monomers, such as homo- or copolymerization of chloroprene and/or dichlorobutadiene |
| 06/10/2004 | US20040110963 Novel hydrazones |
| 06/10/2004 | US20040110839 Compounds and compositions for delivering active agents |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/10/2004 | US20040110817 Dipeptidyl peptidase IV inhibiting fluorinated cyclic amides |
| 06/10/2004 | US20040110806 Dipeptide derivatives |
| 06/10/2004 | US20040110804 4-hydroxy-5-oxo-1-(2-[4-methylpiperazin-1-yl]ethyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid (3,4-dichlorobenzyl)-methyl-amide for human immunodeficiency virus (HIV) treatment |
| 06/10/2004 | US20040110767 Acyclic amide and sulfonamide ligands for the estrogen receptor |
| 06/10/2004 | US20040110754 2-(2-fluoro-phenyl)-cyclopropanecarboxylic acid[1-(2,3-dihydro-benzofuran-5-yl)-ethyl]-amide for example; for pain, migraine, neuropathic pain, bipolar disorders, convulsions, mania, epilepsy, anxiety, depression and neurodegenerative disorders |
| 06/10/2004 | US20040110753 Tyrosine derivatives |
| 06/10/2004 | US20040110748 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 06/10/2004 | US20040110730 Using salts of hydrazine and/or (thio)carbonylamino derivatives of hydrazine for conjugation and immobilization of biomolecules; diagnosis |
| 06/10/2004 | US20040110303 Artificial receptors, building blocks, and methods |
| 06/10/2004 | US20040110229 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence |
| 06/10/2004 | CA2507509A1 Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient |
| 06/09/2004 | EP1426360A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
| 06/09/2004 | EP1425287A1 Processes for preparing calcium salt forms of statins |
| 06/09/2004 | EP1425276A2 Heterocyclic carboxamides and their use as fungicides |
| 06/09/2004 | EP1425029A1 Peptidomimetics of biologically active metallopeptides |
| 06/09/2004 | EP1425009A2 Peptide arginals and methods for treating disseminated intravascular coagulation |
| 06/09/2004 | EP1043310B1 Biphenylamidine derivatives |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1502598A Process for synthesis of cis-1-2-4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1-yl)-phenoxy-ethyl-pyrrolidine |
| 06/09/2004 | CN1502597A Process for synthesis of cis-1-2-4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1)-phenoxy- ethyl-pyrrolidine |
| 06/09/2004 | CN1152860C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 06/09/2004 | CN1152859C Novel N-vinyllactam derivatives and polymer thereof |
| 06/09/2004 | CN1152683C Medicinal composition containing naphthyl compound |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/08/2004 | US6747111 Polymers having low pollydispersity and predictable specific polymer architecture and molecular weight are produced by the process. the polymers produced by the process are suitable for use as binders in automotive oem and refinish coatings. |
| 06/08/2004 | US6747056 K99-5041 substance and production thereof |
| 06/08/2004 | US6747055 Water-soluble drugs and methods for their production |
| 06/08/2004 | US6747054 EP4 receptor selective agonists in the treatment of osteoporosis |
| 06/08/2004 | US6747042 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 06/08/2004 | US6747041 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same |
| 06/08/2004 | US6747027 Selectively inhibits in vitro activity of human matrix metalloprotease-13 over in vitro activity of human matrix metalloprotease-1 |
| 06/08/2004 | US6747023 Sulfonyl derivatives |
| 06/08/2004 | US6746990 Insecticides, acaricides and herbicides |
| 06/08/2004 | US6746989 Substituted benzoylpyrazoles as herbicides |
| 06/08/2004 | US6746722 Fluorine-containing phenylmaleimide derivative, polymer, chemically amplified resist composition, and method for pattern formation using the composition |
| 06/08/2004 | CA2079692C Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 06/03/2004 | WO2004046119A1 Substituted aralkyl derivatives |
| 06/03/2004 | WO2004046106A1 Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides |
| 06/03/2004 | WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 06/03/2004 | WO2004046091A2 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/03/2004 | WO2004045610A1 Aminoalcohol derivatives and their use as beta-3 adrenergic receptor agonists |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004045518A2 Open chain prolyl urea-related modulators of androgen receptor function |
| 06/03/2004 | WO2004037248A3 Modulation of peroxisome proliferator activated receptors activity |
| 06/03/2004 | WO2004033418A3 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | US20040106806 derivatives of hydroxy-pyrene trisulphonic and disulphonic acids |
| 06/03/2004 | US20040106802 Novel compounds and therapeutic uses thereof |
| 06/03/2004 | US20040106795 Peptide deformylase inhibitors |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106792 Biphenyl compound |
| 06/03/2004 | US20040106788 asymmetric hydrogenation of a lactam-enamide; multi-step synthesis |
| 06/03/2004 | US20040106675 class of compounds generally called the "statins" for use in stimulating bone formation and method to identify compounds useful in this regard by assessing their ability to inhibit enzymes in the pathway of isoprenoid synthesis |
| 06/03/2004 | US20040106670 Atorvastatin calcium in a reproducible, pure and crystalline form stable for extended periods of time |
| 06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/03/2004 | US20040106655 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 06/03/2004 | US20040106653 Aminoalcohol derivatives |
| 06/03/2004 | US20040106652 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 06/03/2004 | US20040106650 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 06/03/2004 | US20040106626 amidine containing compounds which inhibit serine proteases |
| 06/03/2004 | US20040106606 Dihydropyrones with tethered heterocycles |
| 06/03/2004 | US20040106593 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 06/03/2004 | US20040106559 for inhibiting proteases |
| 06/03/2004 | US20040106521 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 06/03/2004 | US20040103820 To enhance light resistance by absorbing ultraviolet (UV) light, provide wettability and stabilize a colorant |
| 06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
| 06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | CA2502068A1 Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides |
| 06/02/2004 | EP1424324A1 Crystalline form F of Atorvastatin hemi-calcium salt |
| 06/02/2004 | EP1424322A1 Low molecular weight branched alkenyl succinic acid derivatives prepared from low molecular weight polyisobutene and unsaturated acidic reagents |
| 06/02/2004 | EP1423364A1 Crystalline forms of 'r-(r*,r*)!-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-'phenylamino)carbonyl!-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 06/02/2004 | EP1423363A1 Oral antidiabetic agents |
| 06/02/2004 | EP1423362A1 New mandelic acid derivatives and their use as thrombin inhibitors |
| 06/02/2004 | EP1423356A2 Novel aminobenzoephenones |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | CN1501913A Method for the production of delta <1> pyrrolines |
| 06/02/2004 | CN1501796A Treatment of type 2 diabetes mellitus using inhibitors of dipeptidyl peptidase IV |
| 06/02/2004 | CN1152030C Novel heterocyclic compounds |
| 06/02/2004 | CN1151836C Compounds and compositions for delivering active agents |
| 06/02/2004 | CN1151787C Lactacystine analogs |
| 06/01/2004 | US6743913 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and α-1-blocking action |
| 06/01/2004 | US6743819 Metal catalyst |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743373 Reagent based on enantiopure amino acid in which amino group carries activating group to form active precursor of isocyanate group and carboxyl group is substituted; separation of enantiomers having free functional group |
| 06/01/2004 | US6743262 Perfluoroalkyl haloalkyl ethers and compositions and applications thereof |
| 05/27/2004 | WO2004043951A1 Pyrazole derivatives as modulators of peroxisome proliferator activated receptors |